{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:47:33Z","timestamp":1791578853222,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ajpc.2023.100511","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T17:33:50Z","timestamp":1687455230000},"page":"100511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["High density lipoprotein: When to rethink too much of a good thing"],"prefix":"10.1016","volume":"15","author":[{"given":"Lily N.","family":"Dastmalchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"German","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam R.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajpc.2023.100511_bib0001","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2005.10.033","article-title":"Differential diagnosis of familial high density lipoprotein deficiency syndromes","volume":"186","author":"von Eckardstein","year":"2006","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ajpc.2023.100511_bib0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/vhrm.2008.04.01.39","article-title":"High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease","volume":"4","author":"Kapur","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ajpc.2023.100511_bib0003","doi-asserted-by":"crossref","unstructured":"Race-dependent association of high-density lipoprotein cholesterol levels with incident coronary artery disease. doi:10.1016\/j.jacc.2022.09.027.","DOI":"10.1016\/j.jacc.2022.09.027"},{"issue":"3","key":"10.1016\/j.ajpc.2023.100511_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e328338472d","article-title":"High-density lipoprotein heterogeneity and function in reverse cholesterol transport","volume":"21","author":"Rothblat","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2023.100511_bib0005","unstructured":"HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events | NEJM. Accessed August 23, 2022. https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa1409065."},{"key":"10.1016\/j.ajpc.2023.100511_bib0006","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212525","article-title":"High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease","volume":"7","author":"Kosmas","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.ajpc.2023.100511_bib0007","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL particle number and size as predictors of cardiovascular disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ajpc.2023.100511_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100511_bib0009","first-page":"ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","author":"von Eckardstein","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajpc.2023.100511_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-020-00902-3","article-title":"High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis","volume":"23","author":"Rodriguez","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2023.100511_bib0011","unstructured":"New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1\/4 - ScienceDirect. Accessed January 10, 2023. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109721002497?via%3Dihub."},{"key":"10.1016\/j.ajpc.2023.100511_bib0012","unstructured":"Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy | NEJM. Accessed December 20, 2022. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1107579."},{"key":"10.1016\/j.ajpc.2023.100511_bib0013","unstructured":"Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients | NEJM. Accessed January 10, 2023. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1300955."},{"issue":"22","key":"10.1016\/j.ajpc.2023.100511_bib0014","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2023.100511_bib0015","unstructured":"Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease | NEJM. Accessed January 10, 2023. https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa1706444."},{"issue":"8","key":"10.1016\/j.ajpc.2023.100511_bib0016","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/s41591-022-01936-7","article-title":"Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial","volume":"28","author":"Nicholls","year":"2022","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ajpc.2023.100511_bib0017","article-title":"CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?","author":"Hassan","year":"2016","journal-title":"Glob Cardiol Sci Pract"},{"issue":"9","key":"10.1016\/j.ajpc.2023.100511_bib0018","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.3390\/ijms22094547","article-title":"HDL cholesterol and non-cardiovascular disease: a narrative review","volume":"22","author":"Kjeldsen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.ajpc.2023.100511_bib0019","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2023.100511_bib0020","unstructured":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Accessed January 10, 2023. https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/2021-ESC-Guidelines-on-cardiovascular-disease-prevention-in-clinical-practice."},{"issue":"4","key":"10.1016\/j.ajpc.2023.100511_bib0021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3343\/alm.2022.42.4.415","article-title":"Sex-Specific U-Shaped Relationships Between High-Density Lipoprotein Cholesterol Levels and 10-year Major Adverse Cardiovascular Events: a Nationwide Cohort Study of 5.7 Million South Koreans","volume":"42","author":"Yang","year":"2022","journal-title":"Ann Lab Med"},{"issue":"2","key":"10.1016\/j.ajpc.2023.100511_bib0022","first-page":"325","article-title":"Dyslipidemia in Special Ethnic Populations","volume":"33","author":"Pu","year":"2015","journal-title":"Cardiol Clin"},{"issue":"17","key":"10.1016\/j.ajpc.2023.100511_bib0023","doi-asserted-by":"crossref","first-page":"E6281","DOI":"10.3390\/ijms21176281","article-title":"Gestational Diabetes Type 2: variation in High-Density Lipoproteins Composition and Function","volume":"21","author":"Pasternak","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.ajpc.2023.100511_bib0024","doi-asserted-by":"crossref","first-page":"9955","DOI":"10.1074\/jbc.M010265200","article-title":"Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter","volume":"276","author":"Chambenoit","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpc.2023.100511_bib0025","series-title":"High density lipoproteins: from biological understanding to clinical exploitation. handbook of experimental pharmacology","first-page":"3","article-title":"Structure of HDL: particle Subclasses and Molecular Components","author":"Kontush","year":"2015"},{"issue":"47","key":"10.1016\/j.ajpc.2023.100511_bib0026","first-page":"5908","article-title":"Reverse cholesterol transport: from classical view to new insights","volume":"16","author":"van der Velde","year":"2010","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.ajpc.2023.100511_bib0027","unstructured":"HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk | PLOS ONE. Accessed August 23, 2022. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0114212."},{"key":"10.1016\/j.ajpc.2023.100511_bib0028","unstructured":"Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study | Arteriosclerosis, Thrombosis, and Vascular Biology. Accessed August 23, 2022. https:\/\/www.ahajournals.org\/doi\/10.1161\/01.atv.0000022015.97341.3a?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed."},{"issue":"9","key":"10.1016\/j.ajpc.2023.100511_bib0029","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/ATVBAHA.118.311017","article-title":"HDL (High-Density Lipoprotein) Metrics and Atherosclerotic Risk in Women","volume":"38","author":"El Khoudary","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2023.100511_bib0030","unstructured":"Quality Over Quantity: the Role of HDL Cholesterol Efflux Capacity in Atherosclerotic Cardiovascular Disease. American College of Cardiology. Accessed January 6, 2023. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2017\/02\/01\/07\/34\/http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2farticles%2f2017%2f02%2f01%2f07%2f34%2fquality-over-quantity."},{"key":"10.1016\/j.ajpc.2023.100511_bib0031","unstructured":"Cholesterol efflux pathways, inflammation, and atherosclerosis. Accessed January 6, 2023. https:\/\/www.tandfonline.com\/doi\/epdf\/10.1080\/10409238.2021.1925217?needAccess=true&role=button."},{"key":"10.1016\/j.ajpc.2023.100511_bib0032","unstructured":"HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition | Arteriosclerosis, Thrombosis, and Vascular Biology. Accessed August 23, 2022. https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/ATVBAHA.120.315355?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org."},{"key":"10.1016\/j.ajpc.2023.100511_bib0033","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-021-02443-9","article-title":"HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis","volume":"23","author":"Ferraz-Amaro","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.ajpc.2023.100511_bib0034","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J Clin Invest"},{"issue":"25","key":"10.1016\/j.ajpc.2023.100511_bib0035","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2023.100511_bib0036","doi-asserted-by":"crossref","unstructured":"Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: the EPIC-Norfolk prospective population study | Elsevier Enhanced Reader. doi:10.1016\/j.atherosclerosis.2016.11.010.","DOI":"10.1016\/j.atherosclerosis.2016.11.010"},{"issue":"5","key":"10.1016\/j.ajpc.2023.100511_bib0037","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11883-006-0038-4","article-title":"High-density lipoprotein: is it always atheroprotective?","volume":"8","author":"Ansell","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2023.100511_bib0038","first-page":"72","article-title":"Analysis of the composition of plasma lipoproteins in patients with extensive coronary heart disease using 1H NMR spectroscopy","volume":"49","author":"Papathanasiou","year":"2007","journal-title":"Hell J Cardiol HJC Hell\u0113nik\u0113 Kardiologik\u0113 Epithe\u014dr\u0113s\u0113"},{"key":"10.1016\/j.ajpc.2023.100511_bib0039","doi-asserted-by":"crossref","unstructured":"Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity. doi:10.1161\/CIRCULATIONAHA.120.045713.","DOI":"10.1161\/CIRCULATIONAHA.120.045713"},{"issue":"4","key":"10.1016\/j.ajpc.2023.100511_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/HCO.0000000000000756","article-title":"Cardiovascular effects of preeclampsia","volume":"35","author":"Neerukonda","year":"2020","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ajpc.2023.100511_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2020.104104","article-title":"Combined past preeclampsia and gestational diabetes is associated with a very high frequency of coronary microvascular dysfunction","volume":"134","author":"Kul","year":"2021","journal-title":"Microvasc Res"},{"issue":"23","key":"10.1016\/j.ajpc.2023.100511_bib0042","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st Century: a Multifunctional Roadmap for Future HDL Research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ajpc.2023.100511_bib0043","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/nm.2930","article-title":"The not-so-simple HDL story: a new era for quantifying HDL and cardiovascular risk?","volume":"18","author":"Heinecke","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ajpc.2023.100511_bib0044","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14789450.2018.1402680","article-title":"Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?","volume":"15","author":"Shao","year":"2018","journal-title":"Expert Rev Proteomics"},{"issue":"14","key":"10.1016\/j.ajpc.2023.100511_bib0045","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk","volume":"80","author":"null","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ajpc.2023.100511_bib0046","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ajpc.2023.100511_bib0047","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2023.100511_bib0048","unstructured":"Life's Essential 8: updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: a Presidential Advisory From the American Heart Association | Circulation. Accessed August 23, 2022. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000001078."}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667723000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667723000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:37:35Z","timestamp":1763005055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667723000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":48,"alternative-id":["S2666667723000521"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2023.100511","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High density lipoprotein: When to rethink too much of a good thing","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2023.100511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100511"}}